Article
Inflammatory diseases: is ubiquitinated NEMO at the hub?
Current biology : CB - 29 Dec 2004
Burns Kimberly A, Martinon Fabio
Abstract excerpt
Many patients with Crohn's disease carry mutations in NOD2, a molecule that can both activate and attenuate the pro-inflammatory effects of NF-kappa B. Recent studies implicate NOD2-induced ubiquitination of the NF-kappa B regulator NEMO as a potential means of manipulating the NF-kappa B signal.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
